Davis Blaine 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-03$16.72/sh−3,961$66,235→ 98,839 total - Sale
Common Stock
2025-01-06$16.83/sh−4,028$67,800→ 94,811 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.